{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T18:28:52Z","timestamp":1790188132950,"version":"4.1.0"},"reference-count":109,"publisher":"Informa UK Limited","issue":"1","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Opinion on Drug Safety"],"published-print":{"date-parts":[[2022,1,2]]},"DOI":"10.1080\/14740338.2021.1952979","type":"journal-article","created":{"date-parts":[[2021,7,6]],"date-time":"2021-07-06T13:26:22Z","timestamp":1625577982000},"page":"43-54","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":27,"title":["Safety review of anti-VEGF therapy in patients with myopic choroidal neovascularization"],"prefix":"10.1080","volume":"21","author":[{"given":"Danny S. C.","family":"Ng","sequence":"first","affiliation":[{"name":"The Chinese University of Hong Kong","place":["Hong Kong"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary","family":"Ho","sequence":"additional","affiliation":[{"name":"The Chinese University of Hong Kong","place":["Hong Kong"]},{"name":"Prince of Wales Hospital","place":["New Territories, Hong Kong"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lawrence P.L.","family":"Iu","sequence":"additional","affiliation":[{"name":"The Chinese University of Hong Kong","place":["Hong Kong"]},{"name":"Prince of Wales Hospital","place":["New Territories, Hong Kong"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy Y.Y.","family":"Lai","sequence":"additional","affiliation":[{"name":"The Chinese University of Hong Kong","place":["Hong Kong"]},{"name":"2010 Retina and Macula Centre","place":["Kowloon, Hong Kong"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2021,7,21]]},"reference":[{"key":"e_1_3_4_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9394(14)76618-8"},{"key":"e_1_3_4_4_1","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.62.5.5"},{"key":"e_1_3_4_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2015.01.022"},{"key":"e_1_3_4_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2011.01.018"},{"key":"e_1_3_4_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2013.08.010"},{"key":"e_1_3_4_8_1","doi-asserted-by":"publisher","DOI":"10.1136\/bjophthalmol-2014-305131"},{"key":"e_1_3_4_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0161-6420(96)30515-0"},{"key":"e_1_3_4_10_1","doi-asserted-by":"publisher","DOI":"10.1177\/112067219700700401"},{"key":"e_1_3_4_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0161-6420(99)90484-0"},{"key":"e_1_3_4_12_1","doi-asserted-by":"publisher","DOI":"10.1023\/A:1025488429802"},{"key":"e_1_3_4_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0161-6420(01)01007-7"},{"key":"e_1_3_4_14_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00417-004-0960-5"},{"key":"e_1_3_4_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0161-6420(03)00461-5"},{"key":"e_1_3_4_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.preteyeres.2012.04.001"},{"key":"e_1_3_4_17_1","doi-asserted-by":"publisher","DOI":"10.1097\/IAE.0000000000001227"},{"key":"e_1_3_4_18_1","doi-asserted-by":"publisher","DOI":"10.1097\/IAE.0b013e31818358b2"},{"key":"e_1_3_4_19_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0003554"},{"key":"e_1_3_4_20_1","doi-asserted-by":"publisher","DOI":"10.1097\/IAE.0000000000001744"},{"key":"e_1_3_4_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.survophthal.2007.12.004"},{"key":"e_1_3_4_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0161-6420(02)01998-X"},{"key":"e_1_3_4_23_1","doi-asserted-by":"publisher","DOI":"10.1097\/IAE.0b013e3182411cee"},{"key":"e_1_3_4_24_1","doi-asserted-by":"publisher","DOI":"10.1080\/14712598.2021.1830969"},{"key":"e_1_3_4_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2013.10.023"},{"key":"e_1_3_4_26_1","doi-asserted-by":"publisher","DOI":"10.1159\/000446027"},{"key":"e_1_3_4_27_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.iae.0000242842.14624.e7"},{"key":"e_1_3_4_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.preteyeres.2008.11.005"},{"key":"e_1_3_4_29_1","doi-asserted-by":"publisher","DOI":"10.1177\/019262339902700507"},{"key":"e_1_3_4_30_1","doi-asserted-by":"publisher","DOI":"10.1097\/IAE.0000000000001493"},{"key":"e_1_3_4_31_1","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.12-10260"},{"key":"e_1_3_4_32_1","doi-asserted-by":"publisher","DOI":"10.1038\/eye.2013.8"},{"key":"e_1_3_4_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2013.06.010"},{"key":"e_1_3_4_34_1","doi-asserted-by":"publisher","DOI":"10.1097\/IAE.0000000000002292"},{"key":"e_1_3_4_35_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0227557"},{"key":"e_1_3_4_36_1","doi-asserted-by":"publisher","DOI":"10.1097\/IAE.0000000000001453"},{"key":"e_1_3_4_37_1","doi-asserted-by":"publisher","DOI":"10.1097\/IAE.0000000000002164"},{"key":"e_1_3_4_38_1","doi-asserted-by":"publisher","DOI":"10.1097\/IAE.0000000000001421"},{"key":"e_1_3_4_39_1","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.17-22633"},{"key":"e_1_3_4_40_1","doi-asserted-by":"publisher","DOI":"10.1038\/eye.2012.97"},{"key":"e_1_3_4_41_1","doi-asserted-by":"publisher","DOI":"10.3760\/cma.j.issn.0366-6999.20133045"},{"key":"e_1_3_4_42_1","doi-asserted-by":"publisher","DOI":"10.1097\/IAE.0000000000001236"},{"key":"e_1_3_4_43_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10456-011-9249-6"},{"key":"e_1_3_4_44_1","doi-asserted-by":"publisher","DOI":"10.2147\/OPTH.S80040"},{"key":"e_1_3_4_45_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2015.01.025"},{"key":"e_1_3_4_46_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00417-018-04214-w"},{"key":"e_1_3_4_47_1","doi-asserted-by":"publisher","DOI":"10.2147\/OPTH.S117791"},{"key":"e_1_3_4_48_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00417-016-3396-9"},{"key":"e_1_3_4_49_1","doi-asserted-by":"publisher","DOI":"10.1038\/eye.2015.199"},{"key":"e_1_3_4_50_1","doi-asserted-by":"publisher","DOI":"10.1177\/1120672120963455"},{"key":"e_1_3_4_51_1","doi-asserted-by":"publisher","DOI":"10.2147\/DDDT.S87920"},{"key":"e_1_3_4_52_1","doi-asserted-by":"publisher","DOI":"10.2147\/DDDT.S67536"},{"key":"e_1_3_4_53_1","volume-title":"Presented in angiogenesis, exudation and degeneration meeting","author":"Chen Y","year":"2016","unstructured":"Chen Y Efficacy and safety of conbercept ophthalmic injection in treatment of choroidal neovascularization secondary to pathological myopia (Shiny trial). Presented in angiogenesis, exudation and degeneration meeting 2016, Miami, FL."},{"key":"e_1_3_4_54_1","unstructured":"Lumitin (conbercept) ophthalmic injection drug insert. cited 2021 Mar 31. Available from http:\/\/yao.dxy.com\/drug\/148462.htm"},{"key":"e_1_3_4_55_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41433-019-0516-x"},{"key":"e_1_3_4_56_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12886-019-1164-4"},{"key":"e_1_3_4_57_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-74073-1"},{"key":"e_1_3_4_58_1","doi-asserted-by":"publisher","DOI":"10.1111\/aos.13632"},{"key":"e_1_3_4_59_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12886-021-01877-8"},{"key":"e_1_3_4_60_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2006.05.061"},{"key":"e_1_3_4_61_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0051780"},{"key":"e_1_3_4_62_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcjo.2011.12.009"},{"key":"e_1_3_4_63_1","doi-asserted-by":"publisher","DOI":"10.1097\/IAE.0b013e31826956b7"},{"key":"e_1_3_4_64_1","doi-asserted-by":"publisher","DOI":"10.1136\/bjophthalmol-2012-301639"},{"key":"e_1_3_4_65_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2009.08.008"},{"key":"e_1_3_4_66_1","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.2009.166025"},{"key":"e_1_3_4_67_1","doi-asserted-by":"publisher","DOI":"10.1089\/jop.2011.0141"},{"key":"e_1_3_4_68_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2009.11.003"},{"key":"e_1_3_4_69_1","doi-asserted-by":"publisher","DOI":"10.1097\/IAE.0b013e3182278bae"},{"key":"e_1_3_4_70_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00417-012-2022-8"},{"key":"e_1_3_4_71_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10384-011-0034-2"},{"key":"e_1_3_4_72_1","doi-asserted-by":"publisher","DOI":"10.1097\/IAE.0000000000001313"},{"key":"e_1_3_4_73_1","doi-asserted-by":"publisher","DOI":"10.1136\/bjophthalmol-2012-302973"},{"key":"e_1_3_4_74_1","doi-asserted-by":"publisher","DOI":"10.1097\/IAE.0000000000000632"},{"key":"e_1_3_4_75_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00417-015-3076-1"},{"key":"e_1_3_4_76_1","doi-asserted-by":"publisher","DOI":"10.1159\/000360307"},{"key":"e_1_3_4_77_1","doi-asserted-by":"publisher","DOI":"10.2147\/BTT.S39360"},{"key":"e_1_3_4_78_1","doi-asserted-by":"publisher","DOI":"10.22608\/APO.2017559"},{"key":"e_1_3_4_79_1","first-page":"561","article-title":"Intravitreal ziv-aflibercept: clinical effects and economic impact","volume":"6","author":"Singh SR","year":"2017","unstructured":"Singh SR, Dogra A, Stewart M, et al. Intravitreal ziv-aflibercept: clinical effects and economic impact. Asia Pac J Ophthalmol (Phila). 2017;6:561\u2013568.","journal-title":"Asia Pac J Ophthalmol (Phila)"},{"key":"e_1_3_4_80_1","doi-asserted-by":"publisher","DOI":"10.1136\/bjophthalmol-2014-305302"},{"key":"e_1_3_4_81_1","doi-asserted-by":"publisher","DOI":"10.1097\/IAE.0000000000000913"},{"key":"e_1_3_4_82_1","doi-asserted-by":"publisher","DOI":"10.1136\/bjophthalmol-2016-309994"},{"key":"e_1_3_4_83_1","doi-asserted-by":"publisher","DOI":"10.1097\/IAE.0000000000001440"},{"key":"e_1_3_4_84_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12886-020-01679-4"},{"key":"e_1_3_4_85_1","doi-asserted-by":"publisher","DOI":"10.1136\/bjophthalmol-2018-312453"},{"key":"e_1_3_4_86_1","doi-asserted-by":"publisher","DOI":"10.1097\/IAE.0b013e31826956e4"},{"key":"e_1_3_4_87_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2017.04.028"},{"key":"e_1_3_4_88_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2017.02.018"},{"key":"e_1_3_4_89_1","doi-asserted-by":"publisher","DOI":"10.1097\/IAE.0000000000001489"},{"key":"e_1_3_4_90_1","doi-asserted-by":"publisher","DOI":"10.3109\/15569527.2015.1124886"},{"key":"e_1_3_4_91_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamaophthalmol.2017.0059"},{"key":"e_1_3_4_92_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00417-019-04354-7"},{"key":"e_1_3_4_93_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2013.05.032"},{"key":"e_1_3_4_94_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.oret.2017.07.010"},{"key":"e_1_3_4_95_1","first-page":"749","article-title":"The eye disease case-control study group","volume":"137","author":"Risk factors for idiopathic rhegmatogenous retinal detachment","year":"1993","unstructured":"Risk factors for idiopathic rhegmatogenous retinal detachment. The eye disease case-control study group. Am J Epidemiol. 1993. 137: 749\u2013757.","journal-title":"Am J Epidemiol"},{"key":"e_1_3_4_96_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmjophth-2020-000474"},{"key":"e_1_3_4_97_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2019.04.037"},{"key":"e_1_3_4_98_1","doi-asserted-by":"publisher","DOI":"10.1089\/jir.2019.0030"},{"key":"e_1_3_4_99_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.preteyeres.2015.12.001"},{"issue":"133","key":"e_1_3_4_100_1","first-page":"e1","article-title":"Macular bruch membrane holes in choroidal neovascularization-related myopic macular atrophy by swept-source optical coherence tomography","volume":"162","author":"Ohno-Matsui K","year":"2016","unstructured":"Ohno-Matsui K, Jonas JB, Spaide RF. Macular bruch membrane holes in choroidal neovascularization-related myopic macular atrophy by swept-source optical coherence tomography. Am J Ophthalmol. 2016;162(133\u2013139):e1.","journal-title":"Am J Ophthalmol"},{"key":"e_1_3_4_101_1","doi-asserted-by":"publisher","DOI":"10.1097\/IAE.0000000000001384"},{"key":"e_1_3_4_102_1","doi-asserted-by":"publisher","DOI":"10.1080\/14712598.2020.1782379"},{"key":"e_1_3_4_103_1","doi-asserted-by":"publisher","DOI":"10.1186\/s40942-021-00307-7"},{"key":"e_1_3_4_104_1","article-title":"Two-year results of the phase 3 randomized controlled study of abicipar in neovascular age-related macular degeneration","volume":"19","author":"Khurana RN","year":"2020","unstructured":"Khurana RN, Kunimoto D, Yoon YH, et al. Two-year results of the phase 3 randomized controlled study of abicipar in neovascular age-related macular degeneration. Ophthalmology. 2020 Nov;19:S0161-6420(20)31109-X.","journal-title":"Ophthalmology"},{"key":"e_1_3_4_105_1","article-title":"Risk of inflammation, retinal vasculitis, and retinal occlusion-related events with brolucizumab: post hoc review of HAWK and HARRIER","volume":"15","author":"Mon\u00e9s J","year":"2020","unstructured":"Mon\u00e9s J, Srivastava SK, Jaffe GJ, et al. Risk of inflammation, retinal vasculitis, and retinal occlusion-related events with brolucizumab: post hoc review of HAWK and HARRIER. Ophthalmology. 2020 Nov;15:S0161-6420(20)31075\u20137.","journal-title":"Ophthalmology"},{"key":"e_1_3_4_106_1","unstructured":"Novartis reports one year results of Phase III MERLIN study evaluating Beovu\u00ae every four week dosing and provides update on Beovu clinical program. Media release on 28 May 2021. cited 2021 Jun 6. Available from https:\/\/www.novartis.com\/news\/media-releases\/novartis-reports-one-year-results-phase-iii-merlin-study-evaluating-beovu-every-four-week-dosing-and-provides-update-beovu-clinical-program"},{"key":"e_1_3_4_107_1","doi-asserted-by":"publisher","DOI":"10.1136\/bjophthalmol-2014-305252"},{"key":"e_1_3_4_108_1","doi-asserted-by":"publisher","DOI":"10.1097\/IAE.0000000000001274"},{"key":"e_1_3_4_109_1","doi-asserted-by":"publisher","DOI":"10.47102\/annals-acadmedsg.V39N2p143"},{"key":"e_1_3_4_110_1","doi-asserted-by":"publisher","DOI":"10.1089\/jop.2012.0067"},{"key":"e_1_3_4_111_1","doi-asserted-by":"publisher","DOI":"10.1089\/jop.2015.0056"}],"container-title":["Expert Opinion on Drug Safety"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14740338.2021.1952979","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T12:22:56Z","timestamp":1770898976000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/14740338.2021.1952979"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,21]]},"references-count":109,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1,2]]}},"alternative-id":["10.1080\/14740338.2021.1952979"],"URL":"https:\/\/doi.org\/10.1080\/14740338.2021.1952979","relation":{},"ISSN":["1474-0338","1744-764X"],"issn-type":[{"value":"1474-0338","type":"print"},{"value":"1744-764X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,21]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ieds20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ieds20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2021-04-17","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-07-05","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-07-21","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}